Zhao Lichun | Pharmacology | Best Researcher Award

Published on by Academic Awards

Prof. Dr. Zhao Lichun | Pharmacology | Best Researcher Award

Prof. Dr. Zhao Lichun | Guiyang College of Traditional Chinese Medicine | China

Prof. Dr. Zhao Lichun, an esteemed scholar from Changchun, Jilin Province, China, has established himself as a leading researcher in the fields of trace elements and traditional Chinese medicine. With a Ph.D. and postdoctoral fellowship at Hong Kong Baptist University, he currently serves as a researcher, doctoral supervisor, and Director of the Research Department and Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Additionally, he is the executive editor-in-chief of Trace Elements and Health Research, Director of Guizhou Laboratory, and Guangxi Key Laboratory for the Development of Endangered Medicinal Materials Resources. Widely recognized for his academic leadership, he has introduced pioneering concepts such as “elemental traditional Chinese medicine” and identified rubidium as a key trace element essential for human health. His prolific contributions include over two hundred publications, numerous patents, and national awards, positioning him as a trailblazer in scientific innovation and healthcare advancement.

Publication Profile

Scopus

Education

Prof. Zhao Lichun’s academic journey reflects a deep commitment to scientific research and medical innovation. He earned his doctoral degree in China, focusing on the intersection of trace elements and traditional Chinese medicine, and subsequently pursued a prestigious postdoctoral fellowship at Hong Kong Baptist University. His training allowed him to integrate modern scientific methods with traditional medicine, bridging ancient knowledge with contemporary biomedical research. Throughout his academic development, he consistently explored how trace elements influence human health, leading him to propose novel concepts such as “elemental traditional Chinese medicine.” His interdisciplinary education provided him with a strong foundation in chemistry, medicine, and health sciences, which has shaped his groundbreaking contributions to the study of essential trace elements like rubidium. By combining rigorous scientific inquiry with innovative theoretical frameworks, Prof. Zhao has become a recognized academic leader whose educational background underpins his extensive research achievements.

Experience

Prof. Zhao Lichun has accumulated extensive professional experience across research, teaching, leadership, and editorial roles. He serves as a doctoral supervisor and Director of the Research Department and Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. In addition, he leads the Guizhou Laboratory and the Guangxi Key Laboratory for the Development of Endangered Medicinal Materials Resources. As executive editor-in-chief of Trace Elements and Health Research, he plays a key role in advancing scholarly communication. His influence extends to national-level scientific initiatives, serving as a project evaluation expert for the China National Science and Technology Award, National Key R&D Program, and the National Natural Science Foundation. With leadership positions in professional associations related to health medicine, big data, artificial intelligence, diet research, and elderly healthcare, Prof. Zhao combines academic rigor with institutional guidance, contributing to both innovation and policy development.

Research Focus

Prof. Dr. Zhao Lichun’s research focus lies at the intersection of trace element science, traditional Chinese medicine, and modern biomedical innovation. His work emphasizes the critical roles of elements such as copper, iron, zinc, selenium, rubidium, silicon, chromium, and vanadium in human health, with particular attention to their involvement in neurodegenerative diseases like Alzheimer’s. He has pioneered the concept of “elemental traditional Chinese medicine,” exploring how minerals and trace elements can be harnessed for therapeutic benefits in chronic conditions, cancer, inflammatory diseases, and metabolic disorders. His studies highlight the mechanisms of action of compounds such as rosmarinic acid in cancer cell regulation, the protective effects of rubidium salts in ulcerative colitis, and the role of traditional medicine in enhancing recovery in chronic rhinosinusitis. Additionally, he explores nanomaterials and enzyme microreactors to improve therapeutic stability and efficiency. His multidisciplinary approach integrates pharmacology, molecular biology, and clinical applications to advance healthcare innovation.

Publication Top Notes

  • Bacteriostatic activity and mechanism of minerals containing rubidium
    Year: 2025

  • Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
    Year: 2025 | Citations: 3

  • Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
    Year: 2025 | Citations: 13

  • Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
    Year: 2025

  • Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
    Year: 2024 | Citations: 22

Conclusion

Prof. Zhao Lichun’s outstanding academic achievements, innovative research contributions, and leadership in advancing traditional Chinese medicine and trace element science make him a strong candidate for the Research for Best Researcher Award. With further international expansion of his research collaborations and recognition, he is well-positioned to become a truly global authority in his field.

Sadia Kashif | Pharmacology | Best Researcher Award

Published on by Academic Awards

Assist. Prof. Dr. Sadia Kashif | Pharmacology | Best Researcher Award

Assistant Professor at Ziauddin University, Pakistan

Dr. Sadia Suri Kashif is a dedicated pharmacologist and academic with a Ph.D. in Pharmacology from the University of Karachi. With extensive experience in teaching, research, and academic leadership, she currently serves as an Assistant Professor at Ziauddin University. Her work emphasizes interdisciplinary collaboration and the pursuit of impactful research in pharmacology and health sciences. She actively contributes to scholarly publications, supervises M.Phil research, and engages in academic editorial roles. Known for her innovation in herbal fertility treatments, Dr. Sadia continues to inspire future pharmacists through both classroom teaching and cutting-edge research. 🌿📚

Publication Profile

Orcid

Educational Background

Dr. Sadia Suri Kashif holds a Ph.D. in Pharmacology (2024) with a GPA of 4.0 from the University of Karachi, reflecting her academic excellence and commitment to scientific advancement. She earned her M.Phil in Pharmacology from the same institution in 2008 with a GPA of 3.50, and her foundational B. Pharmacy degree in 2003 with a GPA of 3.26. Her educational journey has been marked by distinction and a focus on research-based learning, laying the groundwork for her contributions to pharmacological education and therapeutic research. 🎓📖💊

Professional Background

With over 15 years of academic and research experience, Dr. Sadia Suri Kashif has taught at prestigious institutions like Ziauddin University and Nazeer Hussain University. Currently serving as Assistant Professor since 2017, she teaches Pharmacology, Physiology, and Anatomy, and leads academic publications like PharmaZia and Pharma Vision. Her earlier roles include Lecturer at Jinnah University and freelance research writer. She also interned at Aga Khan University Hospital. Dr. Sadia is widely respected for her teaching, mentoring, and administrative skills in higher education. 👩‍🏫🔬📄

Awards and Honors

Dr. Sadia Suri Kashif has earned recognition for her multifaceted contributions to pharmaceutical education and research. She has presented research at national and international conferences and actively contributes to academic journals as a reviewer for Discover Toxicology and others. Her leadership roles in organizing workshops and conferences, alongside research excellence, have positioned her as a respected voice in pharmacology. She was involved in patent submissions for herbal fertility treatments and has been consistently acknowledged by academic peers for her commitment to innovation and student mentorship. 🏆📜🌟

Research Focus

Dr. Sadia Suri Kashif’s research centers on pharmacological solutions for infertility, depression, and anxiety, with a strong emphasis on animal models and plant-based therapies. Her current projects explore herbal compositions like Allium cepa and Juglans regia for reproductive health. She supervises M.Phil scholars, evaluates antimicrobial agents, and studies neuroactive compounds. Her two-generation studies in rats have received international publication and recognition. With multiple patents under review, her research aims to merge traditional medicine with modern pharmacology for therapeutic advancement. 🌱🧪🧠

Publication Top Notes

1. Fertility‐Enhancing Potential of P. amygdalas and J. regia Oil Mixture in Wistar Rats: Male/Female Infertility Models Assessment
Year: 2025

2. Fertility-enhancing effects of Prunus amygdalas oil on reproductive functions of male rats: A two-generation study
Year: 2025

3. CLINICAL EFFECTIVENESS OF INSULIN GLARGINE & ASPART VERSUS NPH & REGULAR INSULIN RÉGIME IN TYPE 1 DIABETIC PATIENTS OF PAKISTAN
Year: 2024

4. Emerging Role of Medicinal Herbs on Alzheimer’s Disease and Memory Deficits
Year: 2024

5. Depression Review: Factors and Perspectives
Year: 2019

Conclusion

Dr. Sadia Kashif is a highly accomplished researcher in the fields of pharmaceutical and biomedical sciences, with over 25 peer-reviewed publications in reputable journals such as PLOS One, Avicenna Journal of Phytomedicine, and Metabolic Brain Disease. Her work demonstrates exceptional diversity and innovation, focusing on plant-based therapeutics, reproductive pharmacology, and neuroscience, often using both in-vivo and in-vitro models. She has two patents under review related to herbal remedies for reproductive health, reflecting a strong translational impact. In addition to her research productivity, Dr. Kashif is an active academic mentor, journal reviewer, and contributor to scientific forums and editorial platforms. Her interdisciplinary and socially relevant research, combined with her professional engagement and academic service, make her a deserving candidate for the “Best Researcher Award.”

 

 

Ismael Lares-Asseff | Pharmacology | Lifetime achievement Award

Published on by Academic Awards

Assoc. Prof. Dr. Ismael Lares-Asseff | Pharmacology | Lifetime achievement Award

Assoc. Prof. Dr. Ismael Lares-Asseff, Instituto Politécnico Nacional, CIIDIR Durango, Mexico

Dr. Ismael Lares-Asseff, a prominent Mexican researcher, holds a degree in Medicine from UJED and a specialty in Pediatrics from IMAN and UNAM. He earned his Master’s and Ph.D. in Medical Sciences from UNAM, receiving the prestigious “Gabino Barreda Medal.” Mentored by renowned researcher Dr. Joaquín Cravioto, Dr. Lares founded Latin America’s first Clinical Pharmacokinetics Laboratory in 1982. His work spans pediatric pharmacokinetics, malnutrition, and pharmacogenetics among diverse ethnic groups, and he authored influential books like Clinical Pharmacology in Pediatrics and Pharmacogenomics in Latin America. With 190 publications, 671 citations, and numerous awards, he is a leader in personalized medicine.

 

Publication Profile

Scopus

Orcid

Background and Academic Achievements

Assoc. Prof. Dr. Ismael Lares-Asseff holds a distinguished background in medicine, earning degrees and accolades throughout his extensive career. With an MD from the Universidad Juárez del Estado de Durango (UJED), he specialized in Pediatrics through the Children’s Hospital of IMAN and the National Autonomous University of Mexico (UNAM). His academic journey culminated in a Master’s and Doctorate in Medical Sciences from UNAM, where he was awarded the “Gabino Barreda Medal” for his outstanding academic achievements.

Contributions to Pediatric Research and Clinical Pharmacokinetics

Under the mentorship of Dr. Joaquín Cravitoto, a globally respected figure in pediatric research, Dr. Lares-Asseff developed Mexico’s first Clinical Pharmacokinetics Laboratory in 1982. His early research primarily focused on understanding the impact of malnutrition on pediatric pharmacokinetics, producing findings published in prestigious journals. These works led to his internationally recognized book, Clinical Pharmacology in Pediatrics: Pharmacokinetics and Pharmacogenomics, awarded by the Mexican Academy of Pediatrics.

Conclusion

Assoc. Prof. Dr. Ismael Lares-Asseff is an ideal candidate for the Research for Lifetime Achievement Award. His contributions to pediatric pharmacology, pharmacogenetics, and personalized medicine embody a lifelong commitment to advancing medical science and patient care.

 

Publication Top Notes

  • 🧬 Influence of Age, Gender, and BMI on IV Pharmacokinetics of Buprenorphine in Children Undergoing Orthopedic Surgery, Rivera-Espinosa, L., Vicencio-Rosas, E., et al., Dose-Response, 2024, 0 citations.
  • 👨‍⚕️ Population Pharmacokinetics and Pharmacodynamics of L-asparaginase and Its Impact on Pancreatitis in Leukemia Patients, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Drug and Chemical Toxicology, 2024, 0 citations.
  • 💉 Nutritional Status as a Risk Factor for Doxorubicin Cardiotoxicity in Mexican Children with ALL, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Nutrition and Cancer, 2024, 0 citations.
  • 🧪 Impact of SNPs and Nutrition on Doxorubicin Pharmacokinetics and Cardiotoxicity in Leukemia Patients, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Journal of Oncology Pharmacy Practice, 2023, 3 citations.
  • 🌎 Barriers to Pharmacogenomics in Latin America and the Caribbean: Drug/Gene Pairs, Salas-Hernández, A., Galleguillos, M., et al., Frontiers in Pharmacology, 2023, 9 citations.
  • 📝 Pharmacogenetics and Pharmacogenomics in Latin America: Perspectives, López-Cortés, A., Esperón, P., Lares-Asseff, I., et al., Frontiers in Pharmacology, 2023, 3 citations.
  • 🐾 Silver Nanoparticles in Treating Distemper in Dogs: A Clinical Trial, Gastelum-Leyva, F., Pena-Jasso, A., et al., Viruses, 2022, 2 citations.
  • 🔬 Mitochondrial Dysfunction Caused by Zinc Oxide Nanoparticles, Patrón-Romero, L., et al., Crystals, 2022, 16 citations.
  • 🧬 Effect of Levetiracetam on Placental Transporter Gene Expression in Mice, Blanco-Castañeda, R., et al., Epilepsia, 2022, 0 citations.
  • ❤️ Genetic Polymorphisms and Doxorubicin Cardiotoxicity in Children with ALL, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Pharmacogenetics and Genomics, 2021, 8 citations.